Biotage AB (publ)
BITGF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $9,238,070 | $13,132,752 | $15,389,259 | $13,270,579 |
| - Cash | $420,000 | $434,000 | $370,000 | $318,000 |
| + Debt | $238,000 | $250,000 | $250,000 | $254,000 |
| Enterprise Value | $9,056,070 | $12,948,752 | $15,269,259 | $13,206,579 |
| Revenue | $385,000 | $582,000 | $490,000 | $504,000 |
| % Growth | -33.8% | 18.8% | -2.8% | – |
| Gross Profit | $242,000 | $360,000 | $303,000 | $324,000 |
| % Margin | 62.9% | 61.9% | 61.8% | 64.3% |
| EBITDA | $28,000 | $222,000 | $111,000 | $123,000 |
| % Margin | 7.3% | 38.1% | 22.7% | 24.4% |
| Net Income | $4,000 | $159,000 | $45,000 | $48,000 |
| % Margin | 1% | 27.3% | 9.2% | 9.5% |
| EPS Diluted | 0.05 | 1.98 | 0.56 | 0.6 |
| % Growth | -97.5% | 253.6% | -6.7% | – |
| Operating Cash Flow | $43,000 | $162,000 | $109,000 | $34,000 |
| Capital Expenditures | -$32,000 | -$37,000 | -$48,000 | -$43,000 |
| Free Cash Flow | $11,000 | $125,000 | $61,000 | -$9,000 |